{"id":"NCT00588406","sponsor":"Northwell Health","briefTitle":"Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.","officialTitle":"Emergency Department (ED) Use of Nebulized Budesonide as an Adjunct to Standardized Therapy in Acutely Ill Adults With Refractory Asthma: a Randomized, Double-blinded, Placebo-controlled Trial","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-09","primaryCompletion":"2009-12","completion":"2009-12","firstPosted":"2008-01-08","resultsPosted":"2016-01-21","lastUpdate":"2016-01-21"},"enrollment":95,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Asthma"],"interventions":[{"type":"DRUG","name":"Budesonide","otherNames":["Pulmicort Respules"]},{"type":"DRUG","name":"albuterol","otherNames":["proventil","proair","ventolin","salbutamol"]},{"type":"DRUG","name":"Ipratropium bromide","otherNames":["Atrovent"]},{"type":"DRUG","name":"Prednisone","otherNames":["deltasone"]}],"arms":[{"label":"B","type":"EXPERIMENTAL"},{"label":"P","type":"PLACEBO_COMPARATOR"}],"summary":"To determine whether adding nebulized inhaled steroids to the standard care of acutely ill ED patients with refractory acute asthma helps improve forced expiratory volume at one second (FEV1) and decrease the need for hospitalization.","primaryOutcome":{"measure":"FEV1 Percent Predicted","timeFrame":"4 hours post-randomization","effectByArm":[{"arm":"Budesonide","deltaMin":51.7,"sd":16.8},{"arm":"Placebo","deltaMin":52.6,"sd":15.8}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":3,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":46},"commonTop":[]}}